
One-liner: “AEYE Health develops AI technology for instant diagnosis of diabetic retinopathy, enabling accessible screening for the healthcare sector.”
Company slogan: Best-in-class AI algorithms to detect multiple conditions from fundus images.
Positioning: “AEYE Health is positioned as a pioneer in AI-driven diagnostic solutions for diabetic retinopathy, offering unique technology that allows for instant diagnosis at the point of care.”
Description: “AEYE Health is a venture-backed digital health startup that developed AI algorithms that provide immediate, totally autonomous, point-of-care interpretation of fundus images for various conditions.”
Employees: 36
Website: Visit websiteHeadquarters: “New York, NEW YORK”
Ownership: Privately Held
Founded: 2018
Company type: AI company
Use cases: “diabetic retinopathy screening, glaucoma detection, age-related macular degeneration detection”
Pricing: Dedicated CPT code 92229 for AI diabetic retinopathy screening
Client sector: healthcare
Business model: subscription
Products: AEYE-DS
Is API available: no
Website title: Autonomous Diagnostic Screening | AEYE Health
Website description: “Discover AEYE Health, a digital health company offering fully autonomous, AI-based diagnostic screening solutions for retinal imaging with best-in-class results. AEYE Health enables point-of-care screening for diabetic retinopathy ensuring diagnostic screening is practical, accurate and accessible.”
Linkedin: https://www.linkedin.com/company/aeyehealth
Youtube: –
Instagram: –
Facebook: –
Twitter: –
Crunchbase: –
Email: –